Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people do notice their heart beating faster after starting semaglutide. A raised heart rate is a recognised, if uncommon, effect of GLP-1 medicines — typically mild, temporary, and worth monitoring rather than ignoring. These are prescription-only medicines, and how they affect you individually is something a prescriber needs to know about. If you're experiencing a pounding or racing heart that feels severe, persistent, or comes with dizziness and chest pain, that's a reason to seek medical help promptly, not to wait and see. The sections below explain what's actually happening, what the evidence says, and when to act.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's day three of your second Wegovy pen, you're sitting quietly after dinner, and you suddenly become very aware of your heartbeat. It feels faster than usual. Maybe a bit thumping. Your first thought is probably worry, is this serious?
For most people, it isn't. GLP-1 receptor agonists like semaglutide act on receptors found not just in the gut but in cardiac tissue too, and this can nudge the heart's baseline rate upward slightly. If you want to understand exactly what's happening physiologically, our page on whether semaglutide raises your heart rate covers the mechanism in detail. Clinical trial data for semaglutide 2.4mg recorded average increases in resting heart rate of roughly 1 to 5 beats per minute compared with placebo, a change most participants never consciously felt. You can read the full trial detail in the STEP 1 paper in the New England Journal of Medicine, which remains the core evidence base for Wegovy's weight management licence.
The feeling of palpitations (a flutter, a thud, a sense that your heart is louder than normal) is a separate experience from a measurable rise in rate, and one that some patients do report, especially in the first few weeks or just after stepping up to a higher dose. It tends to ease as the body settles into the new dose level. That pattern mirrors the nausea and tiredness many people feel at first: the body adapting, not the medicine doing something harmful.
One misconception worth setting down gently: a faster heartbeat on semaglutide doesn't mean the medicine is straining your heart. The cardiovascular evidence for semaglutide actually points in the opposite direction for people with established heart disease. The concern, clinically, is about monitoring unusual or persistent symptoms, not about a low-level rate increase in itself.
The distinction that matters is between a mild, passing awareness of your heartbeat and symptoms that suggest something else is going on. If you notice any of the following, contact your GP or prescriber the same day, or call 111 if you can't reach them quickly: a heart rate that feels very fast or irregular rather than just slightly elevated; palpitations accompanied by chest pain, pressure, or tightness; dizziness or feeling faint alongside the racing feeling; shortness of breath that's new or out of proportion to what you're doing.
Severe, persistent stomach pain that radiates to the back is a separate but important warning sign on semaglutide, the MHRA issued a specific Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. That's a different symptom to a racing heart, but it underlines the same principle: unexpected, persistent symptoms aren't something to manage alone by adjusting your dose. Always loop in a clinician.
It's also worth remembering that some of the things that co-occur with semaglutide treatment (reduced food intake, changes in hydration, becoming more physically active) can themselves affect heart rate. Dehydration from nausea or vomiting raises pulse. Starting to exercise more after years of lower activity does too. Unpicking the cause matters, and a prescriber is better placed than a search engine to help you do that. Our detailed page on semaglutide and heart health broadly covers the cardiovascular picture in more depth if that's what you're trying to understand.
A mild, self-resolving increase in heart rate or occasional palpitations is not automatically a reason to stop semaglutide. Stopping abruptly without clinical guidance isn't advised either, any change to your treatment should be discussed with the prescriber who oversees it.
Do tell your prescriber if the feeling is bothering you, if it's lasted more than a few days at a new dose, or if your resting pulse seems consistently higher than your personal norm. They can review whether a slower titration pace makes sense, check for other contributing factors, and decide whether any further assessment is needed. That's exactly the kind of ongoing clinical relationship that makes Wegovy as a long-term treatment work safely.
If you're weighing up what treatment involves before you start, our page on whether Wegovy can make your heart race goes into the specifics of how semaglutide affects resting heart rate and is worth reading alongside the broader side-effect picture. Cost is a practical question that comes up too, Wegovy pricing in the UK has shifted since 2025, and understanding what a legitimate private prescription includes helps you make a clear comparison.
The NHS medicines page for semaglutide lists recognised side effects including palpitations and gives plain guidance on which symptoms need prompt medical attention. It's a reliable first reference alongside whatever your prescriber tells you.
If you'd like a clinical assessment from a GPhC-registered prescriber who will review your full picture (not a checklist) you can check your eligibility with a free consultation at nume. Every review is done by a real clinician, the same day. If you're also thinking about family planning alongside your treatment, our guidance on getting pregnant on Wegovy is worth reading before you make any decisions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.